How Bev is Crushing Cancer

Bev Moir
Teeing up and raising awareness for lung cancer research

Four years after her diagnosis with stage four lung cancer, Bev Moir remains grateful for the scientific advances in biomarker testing and targeted therapy which Sunnybrook specialists have used as part of her treatment plan. Lung cancer is the leading cause of cancer-related death among Canadians, yet lung cancer research is underfunded.

In 2019 Bev began channeling her energy to raise awareness and funds for Sunnybrook’s lung cancer research, launching the ‘Crush It with Bev’ Golf Tournament in 2021. To date, Bev has raised nearly $500,000 for cancer research technologies, testing, and treatments. Funds raised have been a result of the generosity of individual donors, including Bev’s family and friends, as well as the support of corporate sponsors.

In 2023, the ‘Crush It with Bev’ Golf Tournament raised nearly $150,000 to fund clinical research testing the efficacy of liquid biopsy, a test which detects cancer in the blood. This minimally invasive test may have the capacity to help Ontarians facing a lung cancer diagnosis. Last year’s event raised funds to purchase two new pieces of equipment that will improve efficiencies in a patient’s treatment plan.

In addition to fundraising, Bev is also working for change, and strongly advocating for more awareness and access to lung cancer screening at similar levels to those for breast cancer and prostate cancer. Many Canadians do not have access to screenings and as a result, receive a lung cancer diagnosis at advanced stages.

I have a sense of responsibility to raise awareness of lung cancer and advocate for those who are not benefiting from the current science,” Bev says.

Since 2019, the five-year survival rate for lung cancer patients has increased, according to the Canadian Cancer Society. “It is the biggest cause of cancer-related deaths globally, yet most people don’t have it top of mind,” she says. As Bev shares on her blog, with new technologies and better treatments that control the spread of cancer in the lungs, advances are encouraging yet there’s still a long road ahead. A lung cancer diagnosis is still considered a terminal disease.

During a routine CT scan last fall, new growth was found in Bev’s lungs. Dr. Alexander Louie, one of Bev’s specialists, immediately scheduled a type of radiation called Stereotactic Body Radiation Therapy (SBRT) which offers a more precise form of treatment. “I’m benefiting from scientific advancements and leading a high-quality life,” says the retired nurse and wealth management advisor. “I have a sense of responsibility to help.”

Bev is passionate about fundraising to help invent the future of lung cancer care with the ultimate goal to raise $1,000,000. She continues to collect donations throughout the year and is planning the fourth annual 'Crush it with Bev’ golf event this summer. Bev remains a strong advocate for lung cancer research and treatments and is focusing on helping the Sunnybrook lung specialists advance research, technology and treatment for more patients across the province. “A daughter, son, or grandchild, anyone can be diagnosed with lung cancer, there are many different causes,” says Bev. “It’s important to be able to support further research.”

To find out more about launching your own fundraiser, contact events@sunnybrook.ca and learn more here.